Jasbir Seehra Ph.D.
Net Worth
Last updated:
What is Jasbir Seehra Ph.D. net worth?
The estimated net worth of Dr. Jasbir Seehra Ph.D. is at least $7,471,712 as of 8 Apr 2023. He owns shares worth $3,535,912 as insider and has received compensation worth at least $3,935,800 in Keros Therapeutics, Inc..
What is the salary of Jasbir Seehra Ph.D.?
Dr. Jasbir Seehra Ph.D. salary is $787,160 per year as Pres, Chief Executive Officer, Treasurer, & Director in Keros Therapeutics, Inc..
How old is Jasbir Seehra Ph.D.?
Dr. Jasbir Seehra Ph.D. is 70 years old, born in 1955.
What stocks does Jasbir Seehra Ph.D. currently own?
As insider, Dr. Jasbir Seehra Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | Pres, Chief Executive Officer, Treasurer, & Director | 243,856 | $14.5 | $3,535,912 |
What does Keros Therapeutics, Inc. do?
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Jasbir Seehra Ph.D. insider trading
Keros Therapeutics, Inc.
Keros Therapeutics key executives
Keros Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Jasbir Seehra Ph.D. (70) Pres, Chief Executive Officer, Treasurer, & Director
- Dr. Jennifer Lachey Ph.D. (53) Chief Scientific Officer
- Mr. Keith C. Regnante (55) Chief Financial Officer